 A medical record review will be conducted covering 200 patients file undergoing peripheral blood stem cell mobilization in different European centers. Patients will be selected from each of centers, evenly divided between two eras: 1 prior to approval of plerixafor Pre-P era July 2009; and 2 after approval of plerixafor P era . 